Can microRNAs emerge as biomarkers in distinguishing HFpEF versus HFrEF?

International Journal of Cardiology

Volumn 175, Issue 3, 2014, Pages 395-399

  Nair, Nandini ^a,b   Gupta, Sudhiranjan ^c   Collier, Ian X ^a   Gongora, Enrique ^d   Vijayaraghavan, Krishnaswami ^e  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b SACRED HEART MEDICAL CENTER   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e Scottsdale Cardiovascular Center   (United States)

Author keywords

Biomarkers; Heart failure with reduced ejection fraction; MicroRNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; MICRORNA; MICRORNA 122; MICRORNA 124; MICRORNA 124 5P; MICRORNA 1246; MICRORNA 1254; MICRORNA 126; MICRORNA 129 5P; MICRORNA 142 3P; MICRORNA 18B; MICRORNA 22; MICRORNA 320A; MICRORNA 423 5P; MICRORNA 454; MICRORNA 499; MICRORNA 500; MICRORNA 622; MICRORNA 675; MICRORNA 92B; UNCLASSIFIED DRUG;

DIAGNOSTIC ACCURACY; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTOLIC DYSFUNCTION; UPREGULATION; BLOOD; COMPARATIVE STUDY; HEART STROKE VOLUME; PHYSIOLOGY;

BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; MICRORNAS; PROGNOSIS; STROKE VOLUME;

EID: 84905560635     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.06.027     Document Type: Review

References (36)

1. G.C. Fonarow, W.G. Stough, and W.T. Abraham et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry J Am Coll Cardiol 50 2007 768 777
2. M. Gheorghiade, M. Vaduganathan, G.C. Fonarow, and R.O. Bonow Rehospitalization for heart failure: problems and perspectives J Am Coll Cardiol 61 2013 391 403
3. M. Gheorghiade, A.N. Shah, and M. Vaduganathan et al. Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' perspectives Heart Fail Clin 9 2013 285 290
4. V.L. Roger Epidemiology of heart failure Circ Res 113 2013 646 659
5. A.A. Oktay, J.D. Rich, and S.J. Shah The emerging epidemic of heart failure with preserved ejection fraction Curr Heart Fail Rep 10 2013 401 410
6. E. van Rooij, and E.N. Olson MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets J Clin Invest 117 2007 2369 2376
7. E.E. Creemers, A.J. Tijsen, and Y.M. Pinto Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110 2012 483 495
8. M.F. Corsten, R. Dennert, and S. Jochems et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease Circ Cardiovasc Genet 3 2010 499 506
9. S. Fichtlscherer, S. De Rosa, and H. Fox et al. Circulating microRNAs in patients with coronary artery disease Circ Res 107 2010 677 684
10. S. Fichtlscherer, A.M. Zeiher, and S. Dimmeler Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31 2011 2383 2390
11. Y. Goren, M. Kushnir, and B. Zafrir et al. Serum levels of microRNAs in patients with heart failure Eur J Heart Fail 14 2012 147 154
12. S. Gilad, E. Meiri, and Y. Yogev et al. Serum microRNAs are promising novel biomarkers PLoS One 3 2008 e3148 e3154
13. J.E. Fish, M.M. Santoro, and S.U. Morton et al. miR-126 regulates angiogenic signaling and vascular integrity Dev Cell 15 2008 272 284
14. T. Thum, C. Wolf, and J. Fiedler et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure Circulation 116 2007 258 267
15. R. Kumarswamy, and T. Thum Non-coding RNAs in cardiac remodeling and heart failure Circ Res 113 2013 676 689
16. R. Papait, P. Kunderfranco, G.G. Stirparo, M.V. Latronico, and G. Condorelli Long noncoding RNA: a new player of heart failure? J Cardiovasc Transl Res 6 2013 876 886
17. S. Ounzain, R. Micheletti, and T. Beckmann et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs Eur Heart J April 30 2014
18. A. Leung, C. Trac, and W. Jin et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells Circ Res 113 2013 266 278
19. R. Kumarswamy, C. Bauters, and I. Volkmann et al. Circulating long non-coding RNA LIPCAR predicts survival in patients with heart failure Circ Res 114 2014 1569 1575
20. C. Bauters, R. Kumarswamy, and A. Holzmann et al. Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction Int J Cardiol 168 2013 1837 1840
21. A. Zampetaki, P. Willeit, I. Drozdov, S. Kiechl, and M. Mayr Profiling of circulating microRNAs: from single biomarkers to re-wired networks Cardiovasc Res 93 2012 555 562
22. A. Turchinovich, L. Weiz, and B. Burwinkel Extracellular miRNAs: the mystery of their origin and function Trends Biochem Sci 37 2012 460 465
23. N. Nair, S. Kumar, E. Gongora, and S. Gupta Circulating miRNA as novel markers for diastolic dysfunction Mol Cell Biochem 376 2013 33 40
24. Y. Fukushima, M. Nakanishi, H. Nonogi, Y. Goto, and N. Iwai Assessment of plasma miRNAs in congestive heart failure Circ J 75 2011 336 340
25. A.J. Tijsen, E.E. Creemers, and P.D. Moerland et al. MiR-423-5p as a circulating biomarker for heart failure Circ Res 106 2010 1035 1039
26. D.W. Markham, and J.A. Hill MicroRNAs and heart failure diagnosis miR-acle or miR-age? Circ Res 106 2010 1011 1013
27. R.L. Montgomery, T.G. Hullinger, and H.M. Semus et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure Circulation 124 2011 1537 1547
28. V.K. Topkara, and D.L. Mann Clinical applications of miRNAs in cardiac remodeling and heart failure Per Med 7 2010 531 548
29. V.K. Topkara, and D.L. Mann Role of microRNAs in cardiac remodeling and heart failure Cardiovasc Drugs Ther 25 2011 171 182
30. V. Divakaran, and D.L. Mann The emerging role of microRNAs in cardiac remodeling and heart failure 2008 Circ Res 103 2008 1072 1083
31. S.J. Matkovich, Y. Hu, W.H. Eschenbacher, L.E. Dorn, and G.W. Dorn II Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy Circ Res 111 2012 521 531
32. D.D. D'Angelo, Y. Sakata, and J.N. Lorenz et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice Proc Natl Acad Sci U S A 94 1997 8121 8126
33. X. Zhang, G. Azhar, and J.Y. Wei The expression of microRNA and microRNA clusters in the aging heart PLoS One 7 2012 e34688
34. E. Van Rooij, L.B. Sutherland, and J.E. Thatcher et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc Natl Acad Sci U S A 105 2008 13027 13032
35. E. van Rooij, L.B. Sutherland, and N. Liu et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure Proc Natl Acad Sci U S A 103 2006 18255 18260
36. M. Tatsuguchi, H.Y. Seok, and T.E. Callis et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy J Mol Cell Cardiol 42 2007 1137 1141